MoFo Ranks Among FT's 40 Most Innovative U.S. Firms


Life Sciences, Mergers + Acquisitions, and Securities Litigation

MoFo News Item

The Financial Times recognized MoFo among the 40 most innovative firms in its 2014 U.S. Innovative Lawyers Report. We have appeared on the list of most innovative firms every year that the report has been published.

In addition, two of our matters were "commended." Our work defending Clorox against a shareholder class action that sought to undo results on proposals regarding executive compensation was highlighted in the litigation section. We also were commended in the M&A category for our representation of Edison Pharmaceuticals in negotiating its joint venture with Dainippon Sumitomo Corporation.

The U.S. Innovative Lawyers Report, now in its fifth edition, recognizes firms with "the most brilliant lawyers and [that are] coming up with the best solutions."

The full report can be viewed on the Financial Times' site.

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2018 Morrison & Foerster LLP. All rights reserved.